Results 1 to 10 of about 94,112 (278)

Methamphetamine contamination in residential properties and their remediation in Queensland, Australia

Forensic Science International: Reports, 2023
The high use rate for methamphetamine in Australia has led to the emergence of local clandestine production. Contamination of the properties being used for methamphetamine production or consumption poses adverse health risks to occupants, and thus ...
Jianfa Gao, Peter Culshaw, Hieu K.T. Ngo, John Howell, Hong H.T.C. Le, Mengting Yang, Phong K. Thai   +6 more
doaj   +1 more source

SYNTHESIS, CHARACTERIZATION AND APPLICATION OF MEETHAMPHETAMINE – IMPRINTED POLYMERIC SOLID-PHASE

The Iraqi Journal of Agricultural science, 2023
This study was determine methamphetamine by the addition to the glycidyl methacrylate (GMA) monomer resulting from bulk polymerization formation. To acquire the highest adsorption capacity, molar ratios of the template, monomer, and cross-linking agent,
Y. K. Al-Bayati
doaj   +1 more source

Partial MHC/neuroantigen peptide constructs: a potential neuroimmune-based treatment for methamphetamine addiction. [PDF]

PLoS ONE, 2013
Relapse rates following current methamphetamine abuse treatments are very high (∼40-60%), and the neuropsychiatric impairments (e.g., cognitive deficits, mood disorders) that arise and persist during remission from methamphetamine addiction likely ...
Jennifer M Loftis, Clare J Wilhelm, Arthur A Vandenbark, Marilyn Huckans   +3 more
doaj   +1 more source

A mindfulness-based, stress and coping model of craving in methamphetamine users.

PLoS ONE, 2021
There is increasing interest in the role of mindfulness and mindfulness-based interventions to optimize recovery from a substance use disorder (SUD). However, relatively little is known about the theory-based psychological and social pathways whereby ...
Massy Mutumba, Judith T Moskowitz, Torsten B Neilands, Ji-Young Lee, Samantha E Dilworth, Adam W Carrico   +5 more
doaj   +1 more source

Protective Effects of Isoliquiritigenin Against Methamphetamine-Induced Neurotoxicity in Mice

Journal of Pharmacological Sciences, 2009
Isoliquiritigenin (ISL) suppresses cocaine-induced extracellular dopamine levels and has a neuroprotective effect in cocaine-treated rat brain. Here, we examine the effect of ISL on methamphetamine-induced striatal neurotoxicity.
Min Jung Lee, Chae Ha Yang, Jae-Pil Jeon, Meeyul Hwang   +3 more
doaj   +1 more source

Association between genotype of the serotonin transporter-linked polymorphic region of the serotonin transporter gene and age of onset of methamphetamine use: a preliminary analysis

Frontiers in Psychiatry, 2010
Early-onset methamphetamine use increases the lifetime prevalence of methamphetamine dependence. An earlier onset of methamphetamine use leads to greater damage to the terminal ends of serotonin neurons, more reduction in serotonin transporter (5-HTT ...
Bankole A Johnson, Ahmed M Elkashef, Nassima Ait-Daoud, Chamindi Seneviratne, Roberta C Kahn, Shou-Hua Li, Daniel A Bloch, Tyson H Holmes, Xin-Qun Wang, Ming D Li, Francis J Vocci, Jr.   +10 more
doaj   +1 more source

Underlying Mechanism of Combined Effect of Methamphetamine and Morphine on Lethality in Mice and Therapeutic Potential of Cooling

Journal of Pharmacological Sciences, 2005
An increase in polydrug abuse is a major problem worldwide. A previous study showed that coadministration of methamphetamine and morphine induced lethality in rodents and humans.
Mizuho Namiki, Tomohisa Mori, Toshiko Sawaguchi, Shinobu Ito, Tadashi Suzuki   +4 more
doaj   +1 more source

Methamphetamine-mediated astrocytic pyroptosis and neuroinflammation involves miR-152–NLRP6 inflammasome signaling axis

Redox Biology
Methamphetamine is a widely abused drug associated with significant neuroinflammation and neurodegeneration, mainly through the activation of glial cells and neurons in the central nervous system.
Abiola Oladapo, Muthukumar Kannan, Uma Maheswari Deshetty, Seema Singh, Shilpa Buch, Palsamy Periyasamy   +5 more
doaj   +1 more source

A study protocol for the N-ICE trial: A randomised double-blind placebo-controlled study of the safety and efficacy of N-acetyl-cysteine (NAC) as a pharmacotherapy for methamphetamine (“ice”) dependence

Trials, 2019
Background There are currently no approved pharmacotherapies for managing methamphetamine dependence. N-acetylcysteine (NAC) has been found to reduce the craving for methamphetamine and other drugs, but its effect on methamphetamine use and other ...
Rebecca McKetin, Olivia M. Dean, Alyna Turner, Peter J. Kelly, Brendan Quinn, Dan I. Lubman, Paul Dietze, Gregory Carter, Peter Higgs, Amanda L. Baker, Barbara Sinclair, David Reid, Victoria Manning, Nina te Pas, Wenbin Liang, Tamsin Thomas, Ramez Bathish, Margaret Kent, Dayle Raftery, Shalini Arunogiri, Frank Cordaro, Harry Hill, Michael Berk   +22 more
doaj   +1 more source

Gray-matter structure in long-term abstinent methamphetamine users

BMC Psychiatry, 2020
Background Previous studies of brain structure in methamphetamine users have yielded inconsistent findings, possibly reflecting small sample size and inconsistencies in duration of methamphetamine abstinence as well as sampling and analyses methods. Here
Lili Nie, Zeyong Zhao, Xiantao Wen, Wei Luo, Tao Ju, Anlian Ren, Binbin Wu, Jing Li   +7 more
doaj   +1 more source